Overview

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals

Status:
Withdrawn
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
Assessment of the Efficacy and Safety of Hydroxychloroquine (HCQ) Administered as a Prophylaxis for Health Professionals Exposed to COVID19 and Working in Medical Intensive Care Units, in Tunisia. Multicentric, Randomized Comparative Study
Phase:
Phase 3
Details
Lead Sponsor:
Abderrahmane Mami Hospital
Collaborators:
Datametrix
Eshmoun Clinical Research Centre
Treatments:
Hydroxychloroquine